VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by europe10on Mar 06, 2014 3:55pm

117 Views

Post# 22291082

RE:RE:RE:chatter

Investors are realistic.
a no from FDA means that the stock will be instantly worthless, 0 cent. Not 2 or 3.
A yes will mean anything between 15 to maybe 25 cent. So a realistic price level before FDA descision is around here. And a weaker price on a Thursday given that bad news often comes on a Friday is also realistic.

Bullboard Posts

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload